Physician profile
Simon Greenbaum
NPI 1255750816
$15,323.23
in general payments reported to CMS, 2019-2025
16 companies · $394 in 2025
The $394 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12K · 2021: $229 · 2022: $1,403 · 2023: $715 · 2024: $367 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,476.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $11,448.63 | 2020 | |
| Zimmer Biomet Holdings, INC. | $1,421.26 | 2022-2025 | Rosa, Persona, Tapestry |
| Stryker Corporation | $1,003.12 | 2020-2023 | Mako, Gamma |
| Bioventus LLC | $303.37 | 2022-2024 | Durolane, Durolane |
| Medtronic USA, INC. | $300.49 | 2020 | |
| Orthalign INC | $177.67 | 2022 | |
| Depuy Synthes Sales INC. | $161.96 | 2021-2024 | Attune, Monovisc, Orthovisc |
| Kci USA, INC. | $122.19 | 2023 | Prevena |
| Ferring Pharmaceuticals INC. | $118.38 | 2021-2023 | Euflexxa |
| Endo Pharmaceuticals INC. | $78.91 | 2021-2022 | |
| Cumberland Pharmaceuticals, INC. | $57.08 | 2022-2025 | Caldolor |
| Djo, LLC | $40.12 | 2024 | Cmf |
| Merck Sharp & Dohme LLC | $24.67 | 2025 | Bridion |
| Endo USA, INC. | $23.53 | 2024 | Xiaflex |
| Fidia Pharma USA INC. | $22.69 | 2023 | Triluron, Hymovis |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Molnlycke Health Care US, LLC | $19.16 | 2023 | Avance, Mepilex Border Post-Op Ag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Greenbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.